FDA Clearance Tracker · DEN240014
ARC-EX System
Last checked: Nov 20, 2026Latest source record: Dec 19, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Dec 19, 2024
De Novo granted
Time to decision
266 days
Received Mar 28, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN240014
- Device name
- ARC-EX System
- Applicant
- Onward Medical, Inc.
- Applicant location
- Boston, MA
- Received
- Mar 28, 2024
- Decided
- Dec 19, 2024
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device type
- Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation (SDO)
- Device class
- Class II
- Regulation
- 21 CFR 890.5851
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN240014
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Onward Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ARC-EX System510(k)
K251821 · Decided Nov 14, 2025 · 154 days after receipt
Device type: Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation (SDO) · Physical Medicine & Rehabilitation
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.